Shares of Biosante Pharmaceuticals (NASDAQ BPAX) are currently up more than 12% after the company announced positive results from its GVAX leukemia vaccine.
On Tuesday Biosante announced that it raised $17.5 million through a direct sale of stock and options to two institutional investors.
Biosante Pharmaceuticals (NASDAQ BPAX) is currently trading up 18 cents to $1.89 a share.
